Vitiligo: a review

C Bergqvist, K Ezzedine - Dermatology, 2020‏ - karger.com
Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications

WL Chang, CH Ko - Cells, 2023‏ - mdpi.com
Vitiligo is an autoimmune skin disorder caused by dysfunctional pigment-producing
melanocytes which are attacked by immune cells. Oxidative stress is considered to play a …

Vitiligo: a focus on pathogenesis and its therapeutic implications

C Bergqvist, K Ezzedine - The Journal of dermatology, 2021‏ - Wiley Online Library
Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

Vitiligo, from pathogenesis to therapeutic advances: state of the art

F Diotallevi, H Gioacchini, E De Simoni… - International Journal of …, 2023‏ - mdpi.com
Vitiligo is an acquired hypopigmentation of the skin due to a progressive selective loss of
melanocytes; it has a prevalence of 1–2% and appears as rounded, well-demarcated white …

Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy

K Boniface, J Seneschal, M Picardo, A Taïeb - Clinical reviews in allergy & …, 2018‏ - Springer
Vitiligo is an acquired chronic depigmenting disorder of the skin, with an estimated
prevalence of 0.5% of the general population, characterized by the development of white …

Regulatory B cells in cancer

D Michaud, CR Steward, B Mirlekar… - Immunological …, 2021‏ - Wiley Online Library
Tumorigenesis proceeds through discrete steps where acquisition of genetic lesions and
changes in the surrounding microenvironment combine to drive unrestricted neoplastic …

T cell pathology in skin inflammation

R Sabat, K Wolk, L Loyal, WD Döcke… - Seminars in …, 2019‏ - Springer
Forming the outer body barrier, our skin is permanently exposed to pathogens and
environmental hazards. Therefore, skin diseases are among the most common disorders. In …

Vitiligo: pathogenesis, clinical variants and treatment approaches

G Iannella, A Greco, D Didona, B Didona, G Granata… - Autoimmunity …, 2016‏ - Elsevier
Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown,
which usually occurs with asymptomatic whitish patch or macule. Although several …

Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity

Y Wang, S Li, C Li - Medical science monitor: international …, 2019‏ - pmc.ncbi.nlm.nih.gov
Vitiligo is an autoimmune cutaneous disease in which melanocytes are destroyed by CD8+
T cells resulting in disfiguring white spots. From the very beginning of the disease, oxidative …

Vitiligo: a review of aetiology, pathogenesis, treatment, and psychosocial impact

K AL-smadi, M Imran, VR Leite-Silva, Y Mohammed - Cosmetics, 2023‏ - mdpi.com
Vitiligo is an acquired, chronic condition characterised by depigmentation of the epidermis
or by destruction/loss of melanin. Skin cells (melanocytes) are responsible for producing …